Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54K Buy
43
+36
+514% +$449 ﹤0.01% 312
2026
Q1
$92 Buy
+7
New +$123 ﹤0.01% 329
2025
Q4
Sell
-36
Closed -$1.08K 366
2025
Q3
$1.08K Buy
+36
New +$1.24K ﹤0.01% 323
2025
Q2
Sell
-21
Closed -$3.21K 358
2025
Q1
$3.21K Sell
21
-167
-89% -$6.26K ﹤0.01% 337
2024
Q4
$6.49K Buy
188
+56
+42% +$1.63K ﹤0.01% 341
2024
Q3
$3.04K Sell
132
-103
-44% -$2.51K ﹤0.01% 343
2024
Q2
$6.18K Sell
235
-30
-11% -$719 ﹤0.01% 301
2024
Q1
$5.76K Buy
+265
New +$5.63K ﹤0.01% 311

Other funds holding KD

BNP Paribas's KD Position: Q2 2026 in Review

BNP Paribas increased its Kyndryl (KD) stake by 514% in Q2 2026, buying an estimated $449 and bringing the position to 43 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #312.

BNP Paribas first reported a position in KD in Q1 2024 and has held it in 8 quarters since. The position peaked at $6.49K in Q4 2024. 673 funds tracked by Wall St. Rank hold KD as of Q2 2026.

  • BNP Paribas held 43 shares of Kyndryl worth $1.54K as of Q2 2026.
  • BNP Paribas bought 36 Kyndryl shares in Q2 2026, an estimated $449.
  • Kyndryl made up ﹤0.01% of BNP Paribas's portfolio in Q2 2026, its #312 holding.
  • BNP Paribas first reported a position in Kyndryl in Q1 2024 and has held it in 8 quarters since.
  • BNP Paribas's Kyndryl position peaked at $6.49K in Q4 2024.
  • 673 funds tracked by Wall St. Rank held Kyndryl as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.